New insight into the treatment of advanced differentiated thyroid cancer

Arash Safavi, Aparna Vijayasekaran, Marlon A Guerrero

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The vast majority of patients with differentiated thyroid cancer (DTC) are treated successfully with surgery and radioactive iodine ablation, yet the treatment of advanced cases is frustrating and largely ineffective. Systemic treatment with conventional cytotoxic chemotherapy is basically ineffective in most patients with advanced DTC. However, a better understanding of the genetics and biologic basis of thyroid cancers has generated opportunities for innovative therapeutic modalities, resulting in several clinical trials. We aim to delineate the latest knowledge regarding the biologic characteristics of DTC and to describe the available data related to novel targeted therapies that have demonstrated clinical effectiveness.

Original languageEnglish (US)
Article number437569
JournalJournal of Thyroid Research
Volume2012
DOIs
StatePublished - 2012

Fingerprint

Thyroid Neoplasms
Therapeutics
Iodine
Clinical Trials
Drug Therapy

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

New insight into the treatment of advanced differentiated thyroid cancer. / Safavi, Arash; Vijayasekaran, Aparna; Guerrero, Marlon A.

In: Journal of Thyroid Research, Vol. 2012, 437569, 2012.

Research output: Contribution to journalArticle

@article{f090c026e8e84c67982dc7d4589537d3,
title = "New insight into the treatment of advanced differentiated thyroid cancer",
abstract = "The vast majority of patients with differentiated thyroid cancer (DTC) are treated successfully with surgery and radioactive iodine ablation, yet the treatment of advanced cases is frustrating and largely ineffective. Systemic treatment with conventional cytotoxic chemotherapy is basically ineffective in most patients with advanced DTC. However, a better understanding of the genetics and biologic basis of thyroid cancers has generated opportunities for innovative therapeutic modalities, resulting in several clinical trials. We aim to delineate the latest knowledge regarding the biologic characteristics of DTC and to describe the available data related to novel targeted therapies that have demonstrated clinical effectiveness.",
author = "Arash Safavi and Aparna Vijayasekaran and Guerrero, {Marlon A}",
year = "2012",
doi = "10.1155/2012/437569",
language = "English (US)",
volume = "2012",
journal = "Journal of Thyroid Research",
issn = "2090-8067",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - New insight into the treatment of advanced differentiated thyroid cancer

AU - Safavi, Arash

AU - Vijayasekaran, Aparna

AU - Guerrero, Marlon A

PY - 2012

Y1 - 2012

N2 - The vast majority of patients with differentiated thyroid cancer (DTC) are treated successfully with surgery and radioactive iodine ablation, yet the treatment of advanced cases is frustrating and largely ineffective. Systemic treatment with conventional cytotoxic chemotherapy is basically ineffective in most patients with advanced DTC. However, a better understanding of the genetics and biologic basis of thyroid cancers has generated opportunities for innovative therapeutic modalities, resulting in several clinical trials. We aim to delineate the latest knowledge regarding the biologic characteristics of DTC and to describe the available data related to novel targeted therapies that have demonstrated clinical effectiveness.

AB - The vast majority of patients with differentiated thyroid cancer (DTC) are treated successfully with surgery and radioactive iodine ablation, yet the treatment of advanced cases is frustrating and largely ineffective. Systemic treatment with conventional cytotoxic chemotherapy is basically ineffective in most patients with advanced DTC. However, a better understanding of the genetics and biologic basis of thyroid cancers has generated opportunities for innovative therapeutic modalities, resulting in several clinical trials. We aim to delineate the latest knowledge regarding the biologic characteristics of DTC and to describe the available data related to novel targeted therapies that have demonstrated clinical effectiveness.

UR - http://www.scopus.com/inward/record.url?scp=84879192619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879192619&partnerID=8YFLogxK

U2 - 10.1155/2012/437569

DO - 10.1155/2012/437569

M3 - Article

C2 - 23326755

AN - SCOPUS:84879192619

VL - 2012

JO - Journal of Thyroid Research

JF - Journal of Thyroid Research

SN - 2090-8067

M1 - 437569

ER -